Phase I study of UCN-01 and perifosine in patients with relapsed and refractory acute leukemias and high-risk myelodysplastic syndromeIvana Gojo, Edward A. Sausville, Selina M. Luger et al.|Investigational New Drugs|2013Cited by 51